Loading...
•
Dec 31, 2022
Atricure Q4 2022 Earnings Report
Reported fourth quarter and full year financial results.
Key Takeaways
AtriCure reported a revenue of $88.0 million for the fourth quarter of 2022, representing a 20.2% increase compared to the fourth quarter of 2021. The company's loss from operations decreased to $4.1 million, and the net loss per share was $0.09.
Worldwide revenue reached $88.0 million, up 20.2% year over year (21.5% on a constant currency basis).
U.S. revenue increased by 20.7% to $73.9 million, driven by growth in open ablation, pain management, and appendage management product lines.
International revenue grew by 17.8% to $14.1 million (25.4% on a constant currency basis), reflecting growth in appendage management and open ablation franchises.
Loss from operations improved to $4.1 million compared to $12.5 million in the fourth quarter of 2021.
Revenue by Geographic Location
Forward Guidance
Full year 2023 revenue is projected to be approximately $380 million to $387 million, reflecting growth of approximately 15% to 17% over full year 2022. Full year 2023 adjusted EBITDA is expected to break even, with improvements annually thereafter. Full year 2023 adjusted loss per share is expected to be in the range of $1.14 to $1.19.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...